Literature DB >> 29722636

Recent advances in nanomedicine for sepsis treatment.

Simseok A Yuk1, Diego A Sanchez-Rodriguez2, Michael D Tsifansky3, Yoon Yeo1,4.   

Abstract

Sepsis and septic shock are life-threating conditions, which form a continuum of the body's response to overwhelming infection. The current treatment consists of fluid and metabolic resuscitation, hemodynamic and end-organ support, and timely initiation of antibiotics. However, these measures may be ineffective and the sepsis-related mortality toll remains substantial; therefore, an urgent need exists for new therapies. Recently, several nanoparticle (NP) systems have shown excellent protective effects against sepsis in preclinical models, suggesting a potential utility in the management of sepsis and septic shock. These NPs serve as antibacterial agents, provide platforms to immobilize endotoxin adsorbents, interact with inflammatory cells to restore homeostasis and detect biomarkers of sepsis for timely diagnosis. This review discusses the recent developments in NP-based approaches for the treatment of sepsis.

Entities:  

Keywords:  diagnosis; endotoxin; nanoparticles; sepsis; therapy

Mesh:

Substances:

Year:  2018        PMID: 29722636      PMCID: PMC5994832          DOI: 10.4155/tde-2018-0009

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  87 in total

1.  Purification and characterization of chitin deacetylase from Colletotrichum lindemuthianum.

Authors:  I Tsigos; V Bouriotis
Journal:  J Biol Chem       Date:  1995-11-03       Impact factor: 5.157

Review 2.  Functional significance of exosomes applied in sepsis: A novel approach to therapy.

Authors:  Jingjing Wu; Yini Wang; Lanjuan Li
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-14       Impact factor: 5.187

3.  Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.

Authors:  J Turner; Y Cho; N N Dinh; A J Waring; R I Lehrer
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

Review 4.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

5.  Biochemical, pharmaceutical and therapeutic properties of long-acting lithocholic acid derivatized exendin-4 analogs.

Authors:  Su Young Chae; Cheng-Hao Jin; Jae Hee Shin; Sohee Son; Tae Hyung Kim; Seulki Lee; Yu Seok Youn; Youngro Byun; Myung-Shik Lee; Kang Choon Lee
Journal:  J Control Release       Date:  2009-11-10       Impact factor: 9.776

6.  Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study.

Authors:  Paul E Marik; Vikramjit Khangoora; Racquel Rivera; Michael H Hooper; John Catravas
Journal:  Chest       Date:  2016-12-06       Impact factor: 9.410

7.  Platelet-derived exosomes of septic individuals possess proapoptotic NAD(P)H oxidase activity: A novel vascular redox pathway.

Authors:  Mariano Janiszewski; Alípio O Do Carmo; Marcelo A Pedro; Eliézer Silva; Elias Knobel; Francisco R M Laurindo
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

Review 8.  Strategies to improve drug development for sepsis.

Authors:  Mitchell P Fink; H Shaw Warren
Journal:  Nat Rev Drug Discov       Date:  2014-09-05       Impact factor: 84.694

9.  Exosomal miR-223 Contributes to Mesenchymal Stem Cell-Elicited Cardioprotection in Polymicrobial Sepsis.

Authors:  Xiaohong Wang; Haitao Gu; Dongze Qin; Liwang Yang; Wei Huang; Kobina Essandoh; Yigang Wang; Charles C Caldwell; Tianqing Peng; Basilia Zingarelli; Guo-Chang Fan
Journal:  Sci Rep       Date:  2015-09-08       Impact factor: 4.379

10.  Targeting Siglecs with a sialic acid-decorated nanoparticle abrogates inflammation.

Authors:  Shaun Spence; Michelle K Greene; François Fay; Emily Hams; Sean P Saunders; Umar Hamid; Marianne Fitzgerald; Jonathan Beck; Baljinder K Bains; Peter Smyth; Efrosyni Themistou; Donna M Small; Daniela Schmid; Cecilia M O'Kane; Denise C Fitzgerald; Sharif M Abdelghany; James A Johnston; Padraic G Fallon; James F Burrows; Daniel F McAuley; Adrien Kissenpfennig; Christopher J Scott
Journal:  Sci Transl Med       Date:  2015-09-02       Impact factor: 17.956

View more
  7 in total

1.  SPIONs enhances IL-10-producing macrophages to relieve sepsis via Cav1-Notch1/HES1-mediated autophagy.

Authors:  Yujun Xu; Yi Li; Xinghan Liu; Yuchen Pan; Zhiheng Sun; Yaxian Xue; Tingting Wang; Huan Dou; Yayi Hou
Journal:  Int J Nanomedicine       Date:  2019-08-23

Review 2.  Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology.

Authors:  Amit Pant; Irene Mackraj; Thirumala Govender
Journal:  J Biomed Sci       Date:  2021-01-08       Impact factor: 8.410

3.  Omega-3 fatty acids impair miR-1-3p-dependent Notch3 down-regulation and alleviate sepsis-induced intestinal injury.

Authors:  You-Lian Chen; Yin-Jing Xie; Zhen-Mi Liu; Wei-Bu Chen; Ru Zhang; Hong-Xing Ye; Wei Wang; Xue-Yan Liu; Huai-Sheng Chen
Journal:  Mol Med       Date:  2022-01-28       Impact factor: 6.354

4.  Functionalized Erythrocyte Membrane-Coated Nanoparticles for the Treatment of Klebsiella pneumoniae-Induced Sepsis.

Authors:  Jun Liu; Hui Ding; Mingjie Zhao; Fan Tu; Tian He; Lizhu Zhang; Yanfei Jing; Xiaohong Rui; Shiliang Zhang
Journal:  Front Microbiol       Date:  2022-06-16       Impact factor: 6.064

Review 5.  Role of Caveolin-1 in Sepsis - A Mini-Review.

Authors:  Pamella Silva Lannes-Costa; Bruna Alves da Silva Pimentel; Prescilla Emy Nagao
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

Review 6.  Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles.

Authors:  Vo Van Giau; Seong Soo A An; John Hulme
Journal:  Drug Des Devel Ther       Date:  2019-01-18       Impact factor: 4.162

Review 7.  Update on diagnosis and management of sepsis in cirrhosis: Current advances.

Authors:  Cyriac Abby Philips; Rizwan Ahamed; Sasidharan Rajesh; Tom George; Meera Mohanan; Philip Augustine
Journal:  World J Hepatol       Date:  2020-08-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.